Doctors oppose cuts to training budget

March 24, 2006

Doctors' leaders have spoken out against cutbacks to the medical training budget, which they warn could seriously harm patient services.The …

Schering backs merger with Bayer

March 24, 2006
Sales and Marketing

The management of Schering has unveiled a surprise merger deal with fellow German pharmaceutical company Bayer, in a move designed …

Row over cardiovascular targets in new GP contract

March 24, 2006
Research and Development

Patient groups have condemned the new GP contract, saying it ignores a potentially life-threatening condition in tens of thousands of …

Fast growing recruiters thrive on clinical focus

March 23, 2006
Business Services

 Recruitment company Levy Associates have become one of the UK's fastest growing companies thanks to their success in matching talented …

Roche goes online to co-ordinate recruitment

March 23, 2006
Medical Communications

 Roche is using a new automated system to identify the best job candidates faster, using online screening developed by technology …

Protelos ‘unique’ among osteoporosis treatments

March 21, 2006
Sales and Marketing

Servier says new data on its osteoporosis treatment Protelos shows it reduces women's long-term risk of bone fractures by a …

Whatever happened to e-marketing?

March 17, 2006
Sales and Marketing

Is e-marketing dropping off pharma marketing's radar, or are opportunities going begging? Three or four years ago, it was the …

Deal to speed UK uptake of new medicines revealed

March 17, 2006

A new deal between the UK government and the pharmaceutical industry to ensure faster and wider access to new medicines …

Investigators to examine Northwick Park trial safety

March 16, 2006
Research and Development

Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …

World’s biggest DNA project launched

March 16, 2006
Research and Development DNA, MRC, UK Biobank, Wellcome

UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …

Deaths reported in dementia trial

March 16, 2006
Research and Development

Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …

Pharma heading for collision course over cancer drug costs

March 16, 2006
Sales and Marketing

Fears that the pharmaceutical industry could be on a collision course with Europe's healthcare payers over new high priced medicines …

Making and shaping the headlines

March 15, 2006
Medical Communications

Most companies are anxious to court the media to ensure a clearer understanding of their business focus. However, the first …

A place in pharma’s history of innovation

March 15, 2006
Sales and Marketing prix galien

Registration has begun for entrants to the 2006 UK Prix Galien, which takes place at the Houses of Parliament this …

New NHS ratings take tougher line on financial performance

March 15, 2006

New NHS performance ratings will put equal emphasis on a trust's quality of care and financial management. The independent watchdog, …

Crestor hailed as first drug to reverse cardiovascular disease

March 14, 2006
Research and Development

Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …

Schering to fight takeover bid from Merck KGaA

March 14, 2006
Sales and Marketing

A hostile takeover bid has been launched by Merck KGaA for rival German pharmaceutical company Schering.Both companies are enjoying strong …

We’re part of the solution, pharma tells Europe

March 13, 2006
Sales and Marketing

Europe’s pharmaceutical industry body EFPIA has launched a new promotional campaign for the sector, which it hopes will raise awareness …

NHS chief executive resigns amid financial crisis

March 10, 2006

NHS chief executive Nigel Crisp is to step down from the post as debts deepen in the health service.Significant improvements …

Bright future for NicOx after Pfizer glaucoma deal

March 10, 2006
Research and Development

Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …

The Gateway to Local Adoption Series

Latest content